Healthcare provider profile · identity verified

David Gareth Owen, MD

Family Practice · SOUTH JORDAN, UT · NPI 1154411775

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	501	146
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	292	292
Levothyroxine Sodium	Levothyroxine Sodium	288	71
Omeprazole	Omeprazole	232	80
Losartan Potassium	Losartan Potassium	223	68
Lisinopril	Lisinopril	183	51
Gabapentin	Gabapentin	174	61
Shingrix	Varicella-Zoster Ge/As01b/Pf	162	131
Amlodipine Besylate	Amlodipine Besylate	151	44
Metformin Hcl	Metformin Hcl	145	47
Alendronate Sodium	Alendronate Sodium	125	43
Tamsulosin Hcl	Tamsulosin Hcl	125	37
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	113	113
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	110	16
Simvastatin	Simvastatin	105	31
Hydrochlorothiazide	Hydrochlorothiazide	104	38
Metoprolol Succinate	Metoprolol Succinate	101	28
Duloxetine Hcl	Duloxetine Hcl	95	33
Potassium Chloride	Potassium Chloride	95	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	94	28
Metformin Hcl Er	Metformin Hcl	86	26
Pravastatin Sodium	Pravastatin Sodium	86	26
Tramadol Hcl	Tramadol Hcl	84	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	82	25
Rosuvastatin Calcium	Rosuvastatin Calcium	82	24
Albuterol Sulfate Hfa	Albuterol Sulfate	81	27
Mounjaro	Tirzepatide	81	19
Allopurinol	Allopurinol	80	21
Ozempic	Semaglutide	78	16
Trazodone Hcl	Trazodone Hcl	72	25
Furosemide	Furosemide	67	17
Fluticasone Propionate	Fluticasone Propionate	66	25
Fluoxetine Hcl	Fluoxetine Hcl	64	16
Pantoprazole Sodium	Pantoprazole Sodium	63	17
Celecoxib	Celecoxib	62	21
Glimepiride	Glimepiride	58	18
Meloxicam	Meloxicam	58	24
Citalopram Hbr	Citalopram Hydrobromide	49	20
Topiramate	Topiramate	49	suppressed
Twinrix	Hepatitis A And B Vaccine/Pf	48	37
Spironolactone	Spironolactone	47	13
Pregabalin	Pregabalin	46	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	15
Sertraline Hcl	Sertraline Hcl	44	16
Triamcinolone Acetonide	Triamcinolone Acetonide	44	23
Finasteride	Finasteride	43	15
Jardiance	Empagliflozin	41	11
Zolpidem Tartrate	Zolpidem Tartrate	41	14
Trulicity	Dulaglutide	40	suppressed
Alprazolam	Alprazolam	38	suppressed
Buspirone Hcl	Buspirone Hcl	36	11
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Bupropion Xl	Bupropion Hcl	33	11
Baclofen	Baclofen	31	suppressed
Carvedilol	Carvedilol	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	suppressed
Eliquis	Apixaban	31	suppressed
Montelukast Sodium	Montelukast Sodium	31	11
Ondansetron Hcl	Ondansetron Hcl	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	13
Estradiol	Estradiol	28	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Nystatin	Nystatin	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Famotidine	Famotidine	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Atenolol	Atenolol	20	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Fluconazole	Fluconazole	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Colchicine	Colchicine	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	12
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Amoxicillin	Amoxicillin	14	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Temazepam	Temazepam	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error